Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus
Kang Hee Ahn, Sang Soo Kim, Won Jin Kim, Jong Ho Kim, Yun Jeong Nam, Su Bin Park, Yun Kyung Jeon, Bo Hyun Kim, In Joo Kim, Yong Ki Kim
Korean J Intern Med. 2017;32(5):875-882. Published online 2017 May 31 DOI: https://doi.org/10.3904/kjim.2015.153
|
Citations to this article as recorded by
Temporal alteration of serum bilirubin levels and its renoprotective effects in diabetic kidney disease: exploring the hormonal mechanisms
Can Cao, Shuwu Wei, Leijuan He, Chunyao Li, Yizhen Lu, Weiwei Sun, Yaoxian Wang
Frontiers in Endocrinology.2024;[Epub] CrossRef Justicia carnea extracts ameliorated hepatocellular damage in streptozotocin-induced type 1 diabetic male rats via decrease in oxidative stress, inflammation and increasing other risk markers
John Adeolu Falode, Oluwaseun Igbekele Ajayi, Tolulope Victoria Isinkaye, Akinwunmi Oluwaseun Adeoye, Basiru Olaitan Ajiboye, Bartholomew I. C. Brai
Biomarkers.2023; 28(2): 177. CrossRef High‐normal unconjugated bilirubin is associated with decreased risk of chronic kidney disease in type 2 diabetes: A real‐world study
Man‐Rong Xu, Chun‐Hua Jin, Jun‐Xi Lu, Mei‐Fang Li, Lian‐Xi Li
Diabetes/Metabolism Research and Reviews.2023;[Epub] CrossRef Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
Ina G. Panova, Alexander S. Tatikolov
Pharmaceuticals.2023; 16(8): 1077. CrossRef Association between serum bilirubin and estimated glomerular filtration rate in diabetic patients with chronic kidney disease
Tanzia Tahfim, Gazi Sharmin Sultana, Mst. Hasnat Silvi Era, Farjana Yesmin, Rehana Afroze Ruma, Laila Sultana
IMC Journal of Medical Science.2023; : 1. CrossRef Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease
Annalisa Bianco, Claudio Tiribelli, Cristina Bellarosa
Biomedicines.2022; 10(3): 696. CrossRef Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data
Yasunori Aoki, Claudia S. Cabrera, Mario Ouwens, Krister Bamberg, Jenny Nyström, Itamar Raz, Benjamin M. Scirica, Bengt Hamrén, Peter J. Greasley, Dinko Rekić, Abduzhappar Gaipov
PLOS ONE.2022; 17(6): e0269970. CrossRef Bilirubin as a metabolic hormone: the physiological relevance of low levels
Justin F. Creeden, Darren M. Gordon, David E. Stec, Terry D. Hinds
American Journal of Physiology-Endocrinology and Metabolism.2021; 320(2): E191. CrossRef Serum Total Bilirubin and Progression of Chronic Kidney Disease and Mortality: A Systematic Review and Meta-Analysis
Jia Li, Dongwei Liu, Zhangsuo Liu
Frontiers in Medicine.2021;[Epub] CrossRef Main Risk Factors Related to Activities of Daily Living in Non-Dialysis Patients with Chronic Kidney Disease Stage 3–5: A Case–Control Study Jing Chang, Wen-Wen Hou, Yan-Fei Wang, Qian-Mei Sun
Clinical Interventions in Aging.2020; Volume 15: 609. CrossRef Renal impairment markers in type 2 diabetes patients with different types of hyperuricemia
Zhongai Gao, Minxia Zuo, Fei Han, Xinxin Yuan, Mengdi Sun, Xiaochen Li, Ran Liu, Wenhui Jiang, Liyi Zhang, Baocheng Chang, Juhong Yang
Journal of Diabetes Investigation.2019; 10(1): 118. CrossRef Pharmacological actions and therapeutic potentials of bilirubin in islet transplantation for the treatment of diabetes
Qing Yao, Xue Jiang, Longfa Kou, Adelaide T. Samuriwo, He-Lin Xu, Ying-Zheng Zhao
Pharmacological Research.2019; 145: 104256. CrossRef Serum bilirubin level and its impact on the progression of chronic kidney disease
Koray Uludag, Nilufer Oguzhan, Tamer Arıkan, Gulsah Boz
International Urology and Nephrology.2018; 50(9): 1695. CrossRef Relationship between serum bilirubin levels s and the progression of renal function in patients with chronic kidney disease and hyperuricemia
Mengyuan Li, Xinhua Li, Yan Liu, Xinying Liu, Yaxiang Song, Jian Zhao, Chandra Mohan, Tianfu Wu, Ai Peng, Ling Qin
Clinica Chimica Acta.2018; 486: 156. CrossRef Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, Satoshi Higasa, Akihiro Sawada, Tazuko Tokugawa, Kuniyoshi Tanaka, Mina Yanai, Takeshi Kimura
International Journal of STD & AIDS.2018; 29(14): 1424. CrossRef
|